Compare AU
Compare DRUG vs. EIGA
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Aussie Dividends (EIGA). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | EIGA | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 62 |
Median incremental investment | $967.00 | $599.77 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,882.65 | $1,505.40 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | EIGA | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | EIGA.AX was created on 2018-05-07 by Perennial. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to provide investors with an attractive level of tax effective income, paid via monthly distributions. The Fund aims to provide a gross yield, adjusted for applicable franking credits, above that provided by the S&P/ASX 300 Franking Credit Adjusted Daily Total Return Index (Tax-Exempt). |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | BHP Group Ltd (13.12 %) Commonwealth Bank of Australia (6.19 %) CSL Ltd (6.01 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Materials (36.73 %) Financials (26.98 %) Health Care (10.75 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | Australia (97.92 %) United States (2.08 %) |
Management fee | 0.57 % | 0.8 % |
Key Summary
DRUG | EIGA | |
|---|---|---|
Issuer | BetaShares | Perennial |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | S&P/ASX 300 Franking Credit Adjusted Daily Total Return Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.8 % |
Price | $8.15 | $3.90 |
Size | $182.401 million | N/A |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 6.53 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 07/05/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | EIGA | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 62 |
Median incremental investment | $967.00 | $599.77 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,882.65 | $1,505.40 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | EIGA | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | EIGA |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |